15
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Xenobiotic reduction and clinical improvements in capacitor workers: A feasible method

, , , , , & show all
Pages 731-751 | Received 19 Apr 1990, Accepted 21 May 1990, Published online: 15 Dec 2008
 

Abstract

Eleven capacitor workers, occupationally exposed to PCBs and other industrial chemicals, were treated with the detoxification method developed by Hubbard while thirteen co‐workers served as controls. The mean pretreatment PCB levels were 28.0 mg/Kg in adipose and 188.0 μg/L in serum. At post‐treatment, PCBs were reduced in serum by 42% (p<0.05) and in adipose by 30% for the six patients without concurrent disease. Patients with concurrent disease had a 10% reduction in adipose levels, while serum levels remained unchanged. Both adipose and serum PCB levels increased in controls. These differences were maintained at a 4‐month follow‐up examination, though the mean adipose PCB values in all groups were higher than at post‐treatment. Changes in cholesterol, triglycerides, serum AST, ALT, and gGT did not correlate with changes of PCB values. Clinically, at post‐treatment all patients reported a marked improvement in symptoms, with most of these improvements retained at follow‐up. No such improvements were noted in controls. This approach appears to be a feasible treatment modality for symptomatic workers exposed to persistent lipophilic chemicals.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.